SCHEMBL10447404

SCHEMBL10447404

CCOC1CCc2ccccc2C1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
CYP11B1 P15538 1/20 0.55
CYP11B2 P19099 1/20 0.55
HTR1A P08908 1/20 0.47
PLAU P00749 1/20 0.46
MTNR1A P48039 3/20 0.44
MTNR1B P49286 3/20 0.44
IDO1 P14902 2/20 0.44
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
HTR2C P28335 1/20 0.40
SLC6A4 P31645 1/20 0.40
HTR2B P41595 1/20 0.40
GRIN2B Q13224 1/20 0.40
ANPEP P15144 1/20 0.40
CYP19A1 P11511 1/20 0.39
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13049209 0.86 IDO1 (0.52) CYP1A2CYP11B1CYP11B2HTR1AIDO1
SCHEMBL19529545 0.86 HTR1A (0.49) CYP1A2CYP11B1CYP11B2HTR1APLAU
SCHEMBL23368978 0.79 S1PR1 (0.48) CYP1A2CYP11B1CYP11B2HTR1APLAU
SCHEMBL1938520 0.79 HTR1A (0.43) CYP1A2CYP11B1CYP11B2HTR1APLAU
SCHEMBL6311069 0.79 CYP1A2 (0.51) CYP1A2CYP11B1CYP11B2HTR1APLAU
SCHEMBL22524385 0.79 CYP1A2 (0.51) CYP1A2CYP11B1CYP11B2HTR1APLAU
SCHEMBL6570375 0.79 CYP1A2 (0.51) CYP1A2CYP11B1CYP11B2HTR1APLAU
SCHEMBL18785885 0.78 MTNR1A (0.42) CYP1A2CYP11B1CYP11B2HTR1APLAU
SCHEMBL11852553 0.78 PLAU (0.54) HTR1APLAUMTNR1AMTNR1BIDO1
SCHEMBL4431592 0.76 TDP1 (0.42) CYP1A2CYP11B1CYP11B2HTR1APLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11687000-B2 Sulfonium compound, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-27 US disclosed
US-11687000-B2 Sulfonium compound, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-27 US disclosed
US-11560355-B2 Onium salt, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-01-24 US disclosed
US-11333974-B2 Onium salt, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-05-17 US disclosed
US-11215926-B2 Sulfonium compound, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-01-04 US disclosed
US-11022881-B2 Photoacid generator, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-06-01 US disclosed
US-20200319550-A1 SULFONIUM COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-10-08 US disclosed
US-20200223796-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-07-16 US disclosed
EP-3088955-B1 RESIST COMPOSITION AND PATTERNING PROCESS SHINETSU CHEMICAL CO (JP) 2020-06-03 EP disclosed
US-20200159115-A1 NOVEL SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-05-21 US disclosed
US-20130004888-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM AND PATTERN FORMING METHOD USING THE COMPOSITION FUJIFILM CORPORATION (JP) 2013-01-03 US disclosed
US-20130004888-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM AND PATTERN FORMING METHOD USING THE COMPOSITION FUJIFILM CORPORATION (JP) 2013-01-03 US disclosed
US-20120315581-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-12-13 US disclosed
US-20120315581-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-12-13 US disclosed
US-20120308930-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-12-06 US disclosed
US-20120308930-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-12-06 US disclosed
US-20120202158-A1 PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-09 US disclosed
US-20120202158-A1 PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-09 US disclosed
US-20120183903-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-07-19 US disclosed
US-20120183903-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11333974-B2 Onium salt, chemically amplified resist composition, and patterning process ARF5, EIF2B3, KAT5 CYP1A2 3975/4885CYP11B1 3687/4885CYP11B2 3239/4885
US-11560355-B2 Onium salt, chemically amplified resist composition, and patterning process ARF5, EIF2B5, EIF2B3 CYP1A2 3496/4885CYP11B1 2947/4885CYP11B2 2650/4885
US-20200223796-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS ARF5, EIF2B5, EIF2B3 CYP1A2 3496/4885CYP11B1 2947/4885CYP11B2 2650/4885
US-11215926-B2 Sulfonium compound, resist composition, and patterning process HNRNPU, PAG1, LSM14A CYP1A2 4499/4885CYP11B1 4821/4885CYP11B2 4697/4885
US-11687000-B2 Sulfonium compound, chemically amplified resist composition, and patterning process ETV6, PKD1, PKD2 CYP1A2 3279/4885CYP11B1 4237/4885CYP11B2 4030/4885
US-20200319550-A1 SULFONIUM COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS ETV6, PKD1, PKD2 CYP1A2 3279/4885CYP11B1 4237/4885CYP11B2 4030/4885
US-20200159115-A1 NOVEL SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS ETV6, EEF2, EEF1G CYP1A2 4813/4885CYP11B1 4455/4885CYP11B2 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.